Using Sero-Surveillance to Combat the COVID-19 Pandemic
Immunoassays for detecting, tracking, and testing SARS-CoV-2 antibody responses
The humoral immune response to SARS-CoV-2 infection or vaccination produces neutralizing antibodies against various viral proteins, including the nucleocapsid protein and several spike protein domains. Immunoassays are indispensable tools for detecting, tracking, and testing SARS-CoV-2 antibody responses, but limited multiplexing capacity and assay speed can be bottlenecks to meaningful data acquisition.
Download this ebook from Bio-Rad to learn about immunoassays for the sero-surveillance of SARS-CoV-2 immunity signatures in COVID-19 testing, vaccine development, and disease research.
